| 1 |
Ivan Pawlenko |
AT&T |
13 |
| 2 |
Yuping Tan |
Monsanto Technology |
4 |
| 3 |
Michael Lange |
Princeton University |
3 |
| #4 |
William D. Weir |
Rohm And Haas |
2 |
| #4 |
Timothy P. Lenihan |
Johnson & Johnson |
2 |
| #4 |
David Brent Rawlins |
Lexicon Pharmaceuticals |
2 |
| #4 |
Barry C. Lange |
Rohm And Haas |
2 |
| #4 |
Jerome Polizzi |
Nu Visions International |
2 |
| #9 |
William F. Quitty, Jr. |
Visteon Global Technologies |
1 |
| #9 |
Thomas Wiatrowski |
Cordis |
1 |
| #9 |
Peter D. Gardner |
Sarnoff |
1 |
| #9 |
Anna Maria Serbiak |
Kimberly-Clark Worldwide |
1 |
| #9 |
Alan M. Agree |
GE |
1 |
| #9 |
Joyce Marshall |
— |
1 |
| #9 |
Howard J. Yurgevich |
Rosby |
1 |
| #9 |
Christopher M. Holliday |
Mcneil-Ppc |
1 |
| #9 |
Gerald C. Walterick, Jr. |
Betz Laboratories |
1 |
| #9 |
David H. Sullivan |
Arizona Chemical Company |
1 |
| #9 |
David Allen Cooper |
Pq |
1 |
| #9 |
Raphael Rubin |
Thomas Jefferson University |
1 |
| #9 |
William F. Quilty, Jr. |
Visteon Global Technologies |
1 |
| #9 |
Robert J. Graeme, III |
Mcneil-Ppc |
1 |
| #9 |
Jamie J. Swift |
Arris Enterprises |
1 |
| #9 |
Thomas Joseph Caggiano |
Pfizer |
1 |
| #9 |
John Margicin |
Sarnoff |
1 |
| #9 |
Donald R. Weyler |
Rohm And Haas |
1 |
| #9 |
James Robinson |
Valenite |
1 |
| #9 |
Peter Rocket |
— |
1 |
| #9 |
Daniel Maguire Sossaman, II |
Comcast |
1 |
| #9 |
Timothy Schweikert |
Medical Components |
1 |